Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,006 public trials 571 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers

NCT01524978

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Arizona Oncology Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers, LLP Aurora, Colorado, United States
  • Massachusetts General Hospital;Oncology Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 34 locations
View Trial Details
Completed

A Phase I Open Label Study of the Safety and Tolerability of Elotuzumab (BMS-901608) Administered in Combination With Either Lirilumab (BMS-986015) or Urelumab (BMS-663513) in Subjects With Multiple Myeloma

NCT02252263

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University Of Arkansas For Medical Sciences Little Rock, Arkansas, United States
  • The Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • The Ohio State University Columbus, Ohio, United States
View Trial Details
Completed

SST0001 (Roneparstat) in Advanced Multiple Myeloma

NCT01764880

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Manik Chatterjee Würzburg, Germany
  • Division of Hematology, Chaim Sheba Medical Center Tel Litwinsky, Israel
  • U.O. Ematologia con Trapianto, Dipartimento dell'Emergenza e dei Trapianti di Organi Bari, Italy
  • USC Ematologia, Azienda Ospedaliera Papa Giovanni XXIII Bergamo, Italy
View Trial Details

Related conditions